Long Noncoding RNAs MALAT1 and ANRIL Gene Variants and the Risk of Cerebral Ischemic Stroke: An Association Study

2021 ◽  
Author(s):  
Nevine Fathy ◽  
Mona A. Kortam ◽  
Olfat G. Shaker ◽  
Noha H. Sayed
Keyword(s):  
Ischemic Stroke ◽  
Association Study ◽  
Noncoding Rnas ◽  
Long Noncoding Rnas ◽  
Gene Variants ◽  
Cerebral Ischemic Stroke ◽  
Cerebral Ischemic

Irisin Ameliorates Hypoxia/Reoxygenation-Induced Inflammation and Apoptosis in PC12 Cells by Inhibiting TLR4/MYD88 Signaling Pathway

2019 ◽  
Vol 17 (3) ◽  
pp. 329-336
Author(s):  
Wang Jinli ◽  
Xu Fenfen ◽  
Zheng Yuan ◽  
Cheng Xu ◽  
Zhang Piaopiao ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Signaling Pathway ◽  
Pc12 Cells ◽  
Major Complication ◽  
Lactic Dehydrogenase ◽  
Dependent Manner ◽  
Cerebral Ischemic Stroke ◽  
Cerebral Ischemic ◽  
Myd88 Signaling ◽  
Hypoxia Reoxygenation

Cardiovascular disease including cerebral ischemic stroke is the major complication that increases the morbidity and mortality in patients with diabetes mellitus as much as four times. It has been well established that irisin, with its ability to regulate glucose and lipid homeostasis as well as anti-inflammatory and anti-apoptotic properties, has been widely examined for its therapeutic potentials in managing metabolic disorders. However, the mechanism of irisin in the regulation of cerebral ischemic stroke remains unclear. Using PC12 cells as a model, we have shown that hypoxia/reoxygenation inhibits cell viability and increases lactic dehydrogenase. Irisin, in a dose-dependent manner, reversed these changes. The increase in inflammatory mediators (IL-1β, IL-6, and TNF-α) by hypoxia/reoxygenation was reversed by irisin. Furthermore, the cell apoptosis promoted by hypoxia/reoxygenation was also inhibited by irisin. Irisin suppressed TLR4/MyD88 signaling pathway leading to amelioration of inflammation and apoptosis in PC12 cells. Thus, inhibition of TLR4/MyD88 signaling pathway via irisin could be an important mechanism in the regulation of hypoxia/reoxygenation-induced inflammation and apoptosis in PC12 cells.

T Cells and Cerebral Ischemic Stroke

2015 ◽  
Vol 40 (9) ◽  
pp. 1786-1791 ◽  
Author(s):  
Lijuan Gu ◽  
Zhihong Jian ◽  
Creed Stary ◽  
Xiaoxing Xiong
Keyword(s):  
T Cells ◽  
Ischemic Stroke ◽  
Cerebral Ischemic Stroke ◽  
Cerebral Ischemic

scholarly journals Insight Into the Mechanisms and the Challenges on Stem Cell-Based Therapies for Cerebral Ischemic Stroke

2021 ◽  
Vol 15 ◽  
Author(s):  
Huiyong Liu ◽  
Sydney Reiter ◽  
Xiangyue Zhou ◽  
Hanmin Chen ◽  
Yibo Ou ◽  
...  
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Ischemic Stroke ◽  
Potential Effect ◽  
Therapeutic Window ◽  
Ethical Challenges ◽  
Stroke Treatment ◽  
Lesion Core ◽  
Cerebral Ischemic Stroke ◽  
Cerebral Ischemic

Strokes are the most common types of cerebrovascular disease and remain a major cause of death and disability worldwide. Cerebral ischemic stroke is caused by a reduction in blood flow to the brain. In this disease, two major zones of injury are identified: the lesion core, in which cells rapidly progress toward death, and the ischemic penumbra (surrounding the lesion core), which is defined as hypoperfusion tissue where cells may remain viable and can be repaired. Two methods that are approved by the Food and Drug Administration (FDA) include intravenous thrombolytic therapy and endovascular thrombectomy, however, the narrow therapeutic window poses a limitation, and therefore a low percentage of stroke patients actually receive these treatments. Developments in stem cell therapy have introduced renewed hope to patients with ischemic stroke due to its potential effect for reversing the neurological sequelae. Over the last few decades, animal tests and clinical trials have been used to treat ischemic stroke experimentally with various types of stem cells. However, several technical and ethical challenges must be overcome before stem cells can become a choice for the treatment of stroke. In this review, we summarize the mechanisms, processes, and challenges of using stem cells in stroke treatment. We also discuss new developing trends in this field.

scholarly journals Neuroprotective effects of long noncoding RNAs involved in ischemic postconditioning after ischemic stroke

2022 ◽  
Vol 17 (6) ◽  
pp. 1299
Author(s):  
Jian-Hui Guo ◽  
Li-Yan Li ◽  
Wei Ma ◽  
Chun-Yan Li ◽  
Si-Jia Zhang ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Noncoding Rnas ◽  
Long Noncoding Rnas ◽  
Ischemic Postconditioning ◽  
Neuroprotective Effects

scholarly journals MicroRNA-124 Protects Neurons Against Apoptosis in Cerebral Ischemic Stroke

2013 ◽  
pp. n/a-n/a ◽  
Author(s):  
Yang Sun ◽  
Huan Gui ◽  
Qi Li ◽  
Zhu-Min Luo ◽  
Min-Jun Zheng ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Cerebral Ischemic Stroke ◽  
Microrna 124 ◽  
Cerebral Ischemic
Sign in / Sign up

Export Citation Format

Share Document